Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $57.44 -5.79%
EPS Growth %: -215.1%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -215.1%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($1.82). Revenue for the quarter came in at $10.9 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Espey Manufacturing (ESP) Tops Q4 EPS by 24c
- Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
